Provided by Tiger Trade Technology Pte. Ltd.

Karyopharm Therapeutics

1.62
-0.0700-4.14%
Pre-market: 1.650.0300+1.85%04:00 EDT
Volume:800.95K
Turnover:1.30M
Market Cap:36.71M
PE:-0.12
High:1.68
Open:1.68
Low:1.60
Close:1.69
52wk High:10.99
52wk Low:1.60
Shares:22.66M
Float Shares:15.77M
Volume Ratio:0.90
T/O Rate:5.08%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-13.0816
EPS(LYR):-17.9300
ROE:-891.05%
ROA:-47.61%
PB:-0.11
PE(LYR):-0.09

Loading ...

Feb 15, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 09, 2023

Major Issues Report

8-K - Current report
Dec 29, 2022

Correspondence

CORRESP [Cover] - Correspondence
Dec 14, 2022

Major Issues Report

8-K - Current report
Dec 08, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 05, 2022

Major Issues Report

8-K - Current report
Dec 02, 2022

Major Issues Report

8-K - Current report
Nov 03, 2022

Major Issues Report

8-K - Current report
Nov 03, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 04, 2022

Major Issues Report

8-K - Current report
Aug 04, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 28, 2022

Major Issues Report

8-K - Current report
Jun 15, 2022

Major Issues Report

8-K - Current report
Jun 03, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
May 23, 2022

Major Issues Report

8-K - Current report